1500010J02Rik Inhibitors
Chemical inhibitors of the protein 1500010J02Rik act through various mechanistic pathways to inhibit its function. Palbociclib, by selectively inhibiting the cyclin-dependent kinases CDK4 and CDK6, can arrest cell cycle progression, which is a crucial process involving 1500010J02Rik. Similarly, the MEK inhibitors Trametinib, PD0325901, and Selumetinib can block the MAPK/ERK pathway, effectively inhibiting the downstream effects on proteins regulated by this pathway, including 1500010J02Rik. Trametinib's inhibition of MEK1 and MEK2, as well as PD0325901 and Selumetinib's targeted inhibition of MEK1/2, ensures that the signaling cascade that could regulate 1500010J02Rik is interrupted.
Moreover, AZD8055, as an mTOR kinase inhibitor, and Rapamycin, with a similar mechanism but different binding affinity, suppress the mTOR signaling pathway, which is known to control a myriad of cellular processes. This suppression can extend to the operational inhibition of proteins like 1500010J02Rik, which may fall under the regulatory umbrella of the mTOR pathway. The AKT pathway inhibitor MK-2206 can allosterically inhibit AKT, leading to a downstream functional inhibition of 1500010J02Rik. In conjunction, Dasatinib's role as a Src family kinase inhibitor can disrupt signaling pathways that involve Src kinases, potentially affecting the function of 1500010J02Rik. LY294002, by inhibiting PI3K, impedes the PI3K/AKT/mTOR pathway, leading to similar inhibitory effects on the protein. The ROCK inhibitor Y-27632 can interfere with actin cytoskeleton organization, which can affect proteins regulated by these dynamics, including 1500010J02Rik. Additionally, Sunitinib, as a receptor tyrosine kinase inhibitor, can suppress related signaling pathways, while SP600125, by inhibiting JNK, can affect proteins involved in the stress-activated MAPK pathway, such as 1500010J02Rik. Each of these inhibitors, through their specific target pathways, can contribute to the functional inhibition of the protein 1500010J02Rik.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Palbociclib | 571190-30-2 | sc-507366 | 50 mg | $321.00 | ||
Palbociclib selectively inhibits cyclin-dependent kinases CDK4 and CDK6, which may lead to the inhibition of cell cycle progression and cellular proliferation, processes in which 1500010J02Rik could be involved, thereby functionally inhibiting 1500010J02Rik. | ||||||
Trametinib | 871700-17-3 | sc-364639 sc-364639A sc-364639B | 5 mg 10 mg 1 g | $114.00 $166.00 $947.00 | 19 | |
Trametinib is a MEK1 and MEK2 inhibitor that blocks the MAPK/ERK pathway, a signaling pathway that could regulate the activity of 1500010J02Rik, thus inhibiting its function. | ||||||
AZD8055 | 1009298-09-2 | sc-364424 sc-364424A | 10 mg 50 mg | $163.00 $352.00 | 12 | |
AZD8055 is an mTOR kinase inhibitor, which suppresses the mTOR signaling pathway. As mTOR can control various cellular processes, this inhibition could extend to proteins regulated by this pathway, including 1500010J02Rik. | ||||||
MK-2206 dihydrochloride | 1032350-13-2 | sc-364537 sc-364537A | 5 mg 10 mg | $182.00 $332.00 | 67 | |
MK-2206 is an allosteric inhibitor of AKT, a serine/threonine-specific protein kinase that regulates various cellular processes. Inhibition of AKT can lead to functional inhibition of downstream proteins such as 1500010J02Rik. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
Dasatinib is a Src family kinase inhibitor. By inhibiting Src kinases, it could disrupt downstream signaling that regulates the function of proteins like 1500010J02Rik. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that impedes the PI3K/AKT/mTOR pathway. The inhibition of this pathway can lead to functional inhibition of proteins involved in these signaling cascades, including 1500010J02Rik. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 selectively inhibits ROCK, which is involved in actin cytoskeleton organization. Inhibition of ROCK can lead to functional inhibition of proteins that are regulated through cytoskeletal dynamics, including 1500010J02Rik. | ||||||
Sunitinib, Free Base | 557795-19-4 | sc-396319 sc-396319A | 500 mg 5 g | $153.00 $938.00 | 5 | |
Sunitinib is a receptor tyrosine kinase inhibitor, which could inhibit signaling pathways involving receptor tyrosine kinases that regulate the function of proteins such as 1500010J02Rik. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of JNK, which is involved in the stress-activated MAPK pathway. By inhibiting JNK, SP600125 can lead to functional inhibition of proteins regulated by this pathway, including 1500010J02Rik. | ||||||
Selumetinib | 606143-52-6 | sc-364613 sc-364613A sc-364613B sc-364613C sc-364613D | 5 mg 10 mg 100 mg 500 mg 1 g | $29.00 $82.00 $420.00 $1897.00 $3021.00 | 5 | |
Selumetinib is an inhibitor of MEK1/2, thereby blocking the MAPK/ERK pathway which can result in the functional inhibition of downstream proteins such as 1500010J02Rik that are regulated through this pathway. | ||||||